Citations

Mayo Clinic

Showing 10 of 108537 citations.

Acceptability of Nonendoscopic Barrett Esophagus Screening in the Population: Some Initial Promising Answers
Saha, Bibek , Iyer, Prasad G.

American Journal of Gastroenterology | May 16, 2024 | Volume: 119 | Issue: 9 | Pages: 1800-1801

10.14309/ajg.0000000000002835 | PMID 38752629 Get It

A Multicenter Exploration of the APRI/ALBI Score in Associating Liver Partition and Portal Vein Ligation for Staged hepatectomy’ (ALPPS)
Jonas, Jan Philipp , Sander, Sophia, Ardiles, Victoria , Wen, Z, Kysela, Marek , Rauchfuß, Falk , Ullmer, F, Wahba, Roger , Hahn, Oszkár , Fernández-Placencia, Ramiro , Campos, Ricardo Robles, Sparrelid, E., Petrowsky, Henrik , Oberkofler, Christian E. , Rössler, Fabian , Amann, Markus, Linecker, Michael , Müller, Philip C , Wen, Z, Romić, Ivan , Truant, Stéphanie , Reese, Tim , Guidetti, Cristiano , Santol, Jonas , Eshmuminov, Dilmurodjon , Amann, M, Ignatavičius, Povilas , Oberholzer, José , Starlinger, Patrick

British Journal of Surgery | May 16, 2024 | Volume: 111 | Issue: Supplement_3 | Pages: No page available

10.1093/bjs/znae118.029 Get It

Abstract Background Perioperative morbidity and mortality remain a point of concern for the Associating Liver Partition and Portal Vein Ligation for Staged hepatectomy (ALPPS) procedure. Post-hepatectomy liver failure (PHLF) after the second step poses the most significant risk factor for futile outcome. Recovery of liver function after the first step of ALPPS is critically important to allow for sufficient liver function after this surgery. The APRI+ALBI score has been proposed as an easily assessable score to monitor liver function and its dynamic recovery. Aims We explored if the APRI+ALBI score was able to assess liver function recovery after the first step of ALPPS and allow for optimal timing of the 2nd step. Methods Based on the ALPPS registry, patients from 2012 to 2020 with available APRI+ALBI score were included. Postoperative outcomes (PHLF A – C, PHLF B + C, 90-day mortality and severe morbidity) were defined as per standard definitions. The APRI/ALBI score was monitored perioperatively. Results Overall, 464 patients from 16 international participating centers in the ALPPS registry were included. Clinically relevant PHLF (B + C) was observed in 7.5 % and of these 63 % of patients ultimately died due to liver failure. The APRI+ALBI score immediately increased after each surgical intervention and continuously decrease thereafter. Failure of the APRI+ALBI score to decrease until the 2nd step of ALPPS predicted PHLF B+C (p = 0.001; AUC 0.78). Particularly patients with high APRI+ALBI scores and short interstage intervals were at risk to develop PHLF B+C. Conclusion The APRI+ALBI score objectifies liver function recovery after the 1st step of ALPPS and failure to sufficiently decreased is associated with a higher risk for PHLF B+C. This might allow for optimized planning of the 2nd step of ALPPS to allow for sufficient liver function recovery to minimize the risk for PHLF B+C and associated futile outcome.
The Impact of Pyloric Directed Therapy for Gastroparesis
Jue, Terry L., Hasler, William L. , Hasler, W L

Foregut: The Journal of the American Foregut Society | May 16, 2024 | Volume: 4 | Issue: 2 | Pages: 191-199

10.1177/26345161241252932 Get It

Gastroparesis presents with nausea, early satiety, vomiting, bloating, distention, and abdominal pain and is diagnosed by documenting delayed passage of contents from the stomach to the intestines in the absence of mechanical obstruction. Several factors contribute to gastroparesis pathophysiology. Pylorospasm, or increased pyloric contractility, is present in many patients and may be a target for therapy of cases of refractory gastroparesis when medical management is insufficient. Pylorus-directed interventions including botulinum toxin injections, pneumatic balloon dilation, stenting, surgical pyloroplasty, and gastric per-oral endoscopic myotomy are increasingly employed to treat selected patients with gastroparesis who are unresponsive to medications.
Degenerative mitral regurgitation due to flail leaflet: sex-related differences in presentation, management, and outcomes
Avierinos, Jean-Fançois, Tribouilloy, Christophe , Théron, Alexis , Pradier, J., Benfari, Giovanni , Ruşinaru, Dan, Zaffran, Stéphane , Collart, Frédéric , Théron, Alexis , Biagini, Elena , Barbieri, Andrea , Michelena, Hector, Bohbot, Yohann , Essayagh, Benjamin , Enriquez-Sarano, Maurice , Benfari, Giovanni , Zaffran, Stéphane , Bursi, Francesca , Grigioni, Francesco , Vanoverschelde, Jean‐Louis , Resseguier, Noémie , Pasquet, Agnès , Barbieri, Andréa , Michelena, Héctor I. , Vancraeynest, David , Bohbot, Yohann , Essayagh, Benjamin , Enriquez‐Sarano, Maurice

European Heart Journal | May 16, 2024 | Volume: 45 | Issue: 26 | Pages: 2306-2316

10.1093/eurheartj/ehae265 | PMID 38751052 Get It

Abstract Background and Aims Presentation, outcome, and management of females with degenerative mitral regurgitation (DMR) are undefined. We analysed sex-specific baseline clinical and echocardiographic characteristics at referral for DMR due to flail leaflets and subsequent management and outcomes. Methods In the Mitral Regurgitation International Database (MIDA) international registry, females were compared with males regarding presentation at referral, management, and outcome (survival/heart failure), under medical treatment, post-operatively, and encompassing all follow-up. Results At referral, females (n = 650) vs. males (n = 1660) were older with more severe symptoms and higher MIDA score. Smaller cavity diameters belied higher cardiac dimension indexed to body surface area. Under conservative management, excess mortality vs. expected was observed in males [standardized mortality ratio (SMR) 1.45 (1.27–1.65), P < .001] but was higher in females [SMR 2.00 (1.67–2.38), P < .001]. Female sex was independently associated with mortality [adjusted hazard ratio (HR) 1.29 (1.04–1.61), P = .02], cardiovascular mortality [adjusted HR 1.58 (1.14–2.18), P = .007], and heart failure [adjusted HR 1.36 (1.02–1.81), P = .04] under medical management. Females vs. males were less offered surgical correction (72% vs. 80%, P < .001); however, surgical outcome, adjusted for more severe presentation in females, was similar (P ≥ .09). Ultimately, overall outcome throughout follow-up was worse in females who displayed persistent excess mortality vs. expected [SMR 1.31 (1.16–1.47), P < .001], whereas males enjoyed normal life expectancy restoration [SMR 0.92 (0.85–0.99), P = .036]. Conclusions Females with severe DMR were referred to tertiary centers at a more advanced stage, incurred higher mortality and morbidity under conservative management, and were offered surgery less and later after referral. Ultimately, these sex-related differences yielded persistent excess mortality despite surgery in females with DMR, while males enjoyed restoration of life expectancy, warranting imperative re-evaluation of sex-specific DMR management.
Recruiting a prospective community cohort to study Alzheimer's disease and structural and social determinants of health among adults racialized as Black: The ARCHES cohort
Walker, Alexis I. B. , Banks, Christian F., Murphy, Samantha , Zha, Wenqing, Williams, Monique , Day, Gregory S. , Zhu, Yiqi , Ances, Beau M. , Hill, Carl V. , Day, Gregory S , Ances, Beau M , Trani, Jean‐Francois , Williams, Monique M., Hudson, Darrell , Babulal, Ganesh M.

Alzheimer's & Dementia: Translational Research & Clinical Interventions | May 16, 2024 | Volume: 10 | Issue: 2 | Pages: No page available

10.1002/trc2.12473 | PMID 38756718 Get It

Abstract INTRODUCTION This ongoing, prospective study examines the effectiveness of methods used to successfully recruit and retain 238 Black older adults in a longitudinal, observational Alzheimer's disease (AD) study. METHODS Recruitment strategies included traditional media, established research registries, speaking engagements, community events, and snowball sampling. Participants were asked to complete an annual office testing session, blood‐based biomarker collection, optional one‐time magnetic resonance imaging (MRI) scan, and community workshop. RESULTS Within the first 22 months of active recruitment, 629 individuals expressed interest in participating, and 238 enrolled in the ongoing study. Of the recruitment methods used, snowball sampling, community events, and speaking engagements were the most effective. DISCUSSION The systemic underrepresentation of Black participants in AD research impacts the ability to generalize research findings and determine the effectiveness and safety of disease‐modifying treatments. Research to slow, stop, or prevent AD remains a top priority but requires diversity in sample representation. Highlights Provide flexible appointments in the evening or weekends, offering transportation assistance, and allowing participants to complete study visits at alternative locations, such as senior centers or community centers. Continuously monitor and analyze recruitment data to identify trends, challenges, and opportunities for improvement. Implement targeted strategies to recruit participants who are underrepresented based on sex, gender, or education to increase representation. Diversify the research team to include members who reflect the racial and cultural backgrounds of the target population, to enhance trust and rapport with prospective participants.
Aspirin use in essential thrombocythemia: Once‐daily or twice‐daily or not at all?
Tefferi, Ayalew , Barbui, Tiziano

American Journal of Hematology | May 16, 2024 | Volume: 99 | Issue: 8 | Pages: 1450-1453

10.1002/ajh.27369 | PMID 38752361 Get It

Comprehensive profiling of cancer neoantigens from aberrant RNA splicing
Wickland, Daniel P. , McNinch, Colton, Jessen, Erik , Necela, Brian M. , Shreeder, Barath , Knutson, Keith L. , Asmann, Yan W. , Knutson, Keith L. , Lin, Yi

Journal for ImmunoTherapy of Cancer | May 16, 2024 | Volume: 12 | Issue: 5 | Pages: e008988

10.1136/jitc-2024-008988 | PMID 38754917 Get It

Background Cancer neoantigens arise from protein-altering somatic mutations in tumor and rank among the most promising next-generation immuno-oncology agents when used in combination with immune checkpoint inhibitors. We previously developed a computational framework, REAL-neo, for identification, quality control, and prioritization of both class-I and class-II human leucocyte antigen (HLA)-presented neoantigens resulting from somatic single-nucleotide mutations, small insertions and deletions, and gene fusions. In this study, we developed a new module, SPLICE-neo, to identify neoantigens from aberrant RNA transcripts from two distinct sources: (1) DNA mutations within splice sites and (2) de novo RNA aberrant splicings. Methods First, SPLICE-neo was used to profile all DNA splice-site mutations in 11,892 tumors from The Cancer Genome Atlas (TCGA) and identified 11 profiles of splicing donor or acceptor site gains or losses. Transcript isoforms resulting from the top seven most frequent profiles were computed using novel logic models. Second, SPLICE-neo identified de novo RNA splicing events using RNA sequencing reads mapped to novel exon junctions from either single, double, or multiple exon-skipping events. The aberrant transcripts from both sources were then ranked based on isoform expression levels and z-scores assuming that individual aberrant splicing events are rare. Finally, top-ranked novel isoforms were translated into protein, and the resulting neoepitopes were evaluated for neoantigen potential using REAL-neo. The top splicing neoantigen candidates binding to HLA-A*02:01 were validated using in vitro T2 binding assays. Results We identified abundant splicing neoantigens in four representative TCGA cancers: BRCA, LUAD, LUSC, and LIHC. In addition to their substantial contribution to neoantigen load, several splicing neoantigens were potent tumor antigens with stronger bindings to HLA compared with the positive control of antigens from influenza virus. Conclusions SPLICE-neo is the first tool to comprehensively identify and prioritize splicing neoantigens from both DNA splice-site mutations and de novo RNA aberrant splicings. There are two major advances of SPLICE-neo. First, we developed novel logic models that assemble and prioritize full-length aberrant transcripts from DNA splice-site mutations. Second, SPLICE-neo can identify exon-skipping events involving more than two exons, which account for a quarter to one-third of all skipping events.
The Contribution of Psychological Symptoms to Cognitive Difficulties in Youth With Postural Orthostatic Tachycardia Syndrome and Chronic Pain
Owens, Michele Tsai , Sim, Leslie , Kirsch, Alexandra C. , Homan, Kendra J. , Zaccariello, Michael J. , Sawchuk, Nicholas, Geske, Jennifer R. , Harbeck‐Weber, Cynthia , Tsai Owens, Michele, Fischer, Philip R. , Kirsch, Alexandra , Homan, Kendra, Zaccariello, Michael, Geske, Jennifer, Harbeck‐Weber, Cynthia , Geske, Jennifer , LeMahieu, Allison

Journal of Child Neurology | May 16, 2024 | Volume: 39 | Issue: 3-4 | Pages: 104-112

10.1177/08830738241236815 | PMID 38751190 Get It

Introduction Subjectively experienced cognitive difficulties are common in youth with postural orthostatic tachycardia syndrome. The pathophysiological and psychological contributions of these cognitive impairments remain unclear. Method Participants were 96 adolescents and young adults diagnosed with postural orthostatic tachycardia syndrome and admitted to an intensive pain treatment program. Participants completed cognitive assessment and measures of postural orthostatic tachycardia syndrome symptoms, pain intensity, pain catastrophizing, anxiety, depression, and functional disability. Results Self-reported autonomic symptom intensity, but not severity of heart rate change, was associated with cognitive performance. Symptoms of depression were associated with decreases in most measures of cognitive functioning. Pain intensity, pain catastrophizing, and depression but not cognitive scores and physiological measures, were significant predictors of disability. Conclusion Depression appears to be a significant contributor to the cognitive difficulties in youth with postural orthostatic tachycardia syndrome. These findings highlight the importance of assessing and treating affective symptoms in this population along with medical and lifestyle approaches to treating postural orthostatic tachycardia syndrome symptoms.
The Impact of Changing Antithrombotic Management in Patients With Atrial Fibrillation and Ischemic Cerebrovascular Events Despite Anticoagulation
Harahsheh, Ehab , Elshaigi, Omer , Alhayek, Nour, Buckner, Skye A., Quillen, Jaxon , O’Carroll, Cumara B. , Dumitrașcu, Oana , Quillen, Jaxon K, Harahsheh, Ehab

The Neurohospitalist | May 16, 2024 | Volume: 14 | Issue: 4 | Pages: 379-388

10.1177/19418744241254897 | PMID 39308467 Get It

Background Patients with atrial fibrillation (AF) are at increased risk of ischemic cerebrovascular events despite anticoagulants (AC). We aim to evaluate whether changing AC or adding antiplatelet therapy to anticoagulants (AP + AC) in patients with AF presenting with acute ischemic stroke (AIS) or transient ischemic attack (TIA) despite AC, decreases the risk of recurrent AIS/TIA compared to patients continued on same AC regimen. Methods Patients with AF on AC presenting with AIS or TIA at our center between 2011- 2021 were included. Data on Demographics, index event, antithrombotic therapy before and after index event, recurrent AIS/TIA, or major bleeding events (MBE) were extracted. Cox proportional hazards models were used to compare outcomes between AC unchange vs AC change, and AP + AC vs AC only groups. Results One hundred eighty-five patients were included (mean age 78.3 years; 62% males, median follow-up 9 months (IQR 1-34)). Seventeen patients (9%) had AC change, 100 (54%) received AP + AC, 39 (21%) had recurrent AIS/TIA, and 27 (15%) had MBE following index event. No difference was observed between AC unchange vs AC change and AP + AC vs AC only groups regarding recurrent AIS/TIA (HR 1.72 [.65-4.57], P = .27 and HR 1.02 [.53- 1.98], P = .95, respectively) or MBE (HR .85 [.19-3.67], P = .83 and HR 1.49 [.67-3.33)], P = .33, respectively). Fourteen vascular neurologists treated this cohort and 9(64%) implemented AC changes. Conclusion In this single center retrospective study of 185 patients with AF and AIS/TIA despite AC, changing AC or adding AP agents did not decrease the risk of ischemic cerebrovascular events.
Endoscopy-related musculoskeletal injuries to endoscopists: time for an “ergonomic time-out”
Wagh, Mihir S.

Endoscopy | May 15, 2024 | Volume: 56 | Issue: 08 | Pages: 620-621

10.1055/a-2307-6443 | PMID 38749464 Get It